Ih Chang
Cerevel Therapeutics (United States)(US)
Publications by Year
Research Areas
Multiple Sclerosis Research Studies, Polyomavirus and related diseases, Pneumonia and Respiratory Infections, Plant Virus Research Studies, Bacterial Infections and Vaccines
Most-Cited Works
- → Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children(2000)2,296 cited
- → Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS(2020)525 cited
- → Immunogenicity and Impact on Nasopharyngeal Carriage of a Nonavalent Pneumococcal Conjugate Vaccine(1999)523 cited
- → Safety and Immunogenicity of Heptavalent Pneumococcal Vaccine Conjugated to CRM197 in United States Infants(1998)395 cited
- → Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial(2003)388 cited
- → Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants(2003)384 cited
- → Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies(2007)368 cited
- → Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension(2018)329 cited
- → Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies(2017)312 cited
- → Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers(1999)274 cited